Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterizing HIV manifestations and treatment outcomes of perinatally infected adolescents in Asia.
Chokephaibulkit K, Kariminia A, Oberdorfer P, Nallusamy R, Bunupuradah T, Hansudewechakul R, Dung KT, Saphonn V, Kumarasamy N, Lumbiganon P, Viet do C, Kurniati N, Yusoff NK, Razali K, Fong SM, Khanh TH, Wati DK, Sohn AH; TREAT Asia Pediatric HIV Observational Database. Chokephaibulkit K, et al. Among authors: lumbiganon p. Pediatr Infect Dis J. 2014 Mar;33(3):291-4. doi: 10.1097/INF.0b013e3182a18223. Pediatr Infect Dis J. 2014. PMID: 23942457 Free PMC article.
Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
Kosalaraksa P, Bunupuradah T, Engchanil C, Boonrak P, Intasan J, Lumbiganon P, Burger D, Ruxrungtham K, Schutz M, Ananworanich J; HIV-NAT 017 Study Team. Kosalaraksa P, et al. Among authors: lumbiganon p. Pediatr Infect Dis J. 2008 Jul;27(7):623-8. doi: 10.1097/INF.0b013e31816b4539. Pediatr Infect Dis J. 2008. PMID: 18520443 Clinical Trial.
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection.
Ananworanich J, Kosalaraksa P, Siangphoe U, Engchanil C, Pancharoen C, Lumbiganon P, Intasan J, Apateerapong W, Chuenyam T, Ubolyam S, Bunupuradah T, Lange J, Cooper DA, Phanuphak P; HIV-NAT 010 Study Team. Ananworanich J, et al. Among authors: lumbiganon p. AIDS Res Ther. 2008 Oct 28;5:24. doi: 10.1186/1742-6405-5-24. AIDS Res Ther. 2008. PMID: 18957095 Free PMC article.
Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks.
Bunupuradah T, van der Lugt J, Kosalaraksa P, Engchanil C, Boonrak P, Puthanakit T, Mengthaisong T, Mahanontharit A, Lumbiganon P, Tompkins E, Burger D, Ruxrungtham K, Ananworanich J; HIV-NAT 017 Study Team. Bunupuradah T, et al. Among authors: lumbiganon p. Antivir Ther. 2009;14(2):241-8. Antivir Ther. 2009. PMID: 19430099
Cohort profile: the TREAT Asia pediatric HIV observational database.
Kariminia A, Chokephaibulkit K, Pang J, Lumbiganon P, Hansudewechakul R, Amin J, Kumarasamy N, Puthanakit T, Kurniati N, Nik Yusoff NK, Saphonn V, Fong SM, Razali K, Nallusamy R, Sohn AH, Sirisanthana V. Kariminia A, et al. Among authors: lumbiganon p. Int J Epidemiol. 2011 Feb;40(1):15-24. doi: 10.1093/ije/dyp358. Epub 2010 Jan 25. Int J Epidemiol. 2011. PMID: 20100820 Free PMC article. No abstract available.
404 results